ProText Mobility, Inc. (TXTM)
0.0058
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
ProText Mobility Shareholders Equity (Quarterly) : 611.11M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 611.11M |
| March 31, 2026 | 611.12M |
| December 31, 2025 | 546.14M |
| September 30, 2025 | 510.60M |
| June 30, 2025 | 504.31M |
| March 31, 2025 | 254.33M |
| December 31, 2024 | 254.33M |
| September 30, 2024 | 54.34M |
| June 30, 2024 | 54.35M |
| March 31, 2024 | 14.36M |
| December 31, 2023 | 14.38M |
| September 30, 2023 | 14.55M |
| June 30, 2023 | 14.56M |
| March 31, 2023 | 14.58M |
| December 31, 2022 | 14.43M |
| September 30, 2022 | -0.8716M |
| June 30, 2022 | -0.8737M |
| March 31, 2022 | -0.9487M |
| December 31, 2021 | -1.161M |
| September 30, 2021 | -1.093M |
| June 30, 2021 | -1.142M |
| March 31, 2021 | -1.540M |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 0.3541M |
| September 30, 2018 | 0.4156M |
| June 30, 2018 | 0.4672M |
| March 31, 2018 | 0.5839M |
| December 31, 2017 | 0.6927M |
| September 30, 2017 | 0.6898M |
| June 30, 2017 | 0.6657M |
| March 31, 2017 | 0.7572M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | -6.558M |
| June 30, 2014 | -6.510M |
| March 31, 2014 | -5.941M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | -14.68M |
| Longevity Health Holdings, Inc. | -8.699M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Agenus, Inc. | -199.08M |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 611.30M |
| Total Liabilities (Quarterly) | 0.1916M |
| Debt to Equity Ratio | 0.0003 |
| Current Ratio | 3190.50 |
| Net Debt Paydown Yield | -0.04% |